Clinical Trial Update: Tau Biomarkers in Late-onset Psychosis (LOP)

View source ↗

Summary

A clinical trial sponsored by Jeremy Koppel is investigating tau biomarkers in late-onset psychosis, including late-onset schizophrenia and delusional disorder.…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Delusional Disorder
• Late-onset Schizophrenia

Snippet

Sponsor: Jeremy Koppel | Conditions: Late Onset Schizophrenia, Delusional Disorder (Late Onset) | Status: RECRUITING